Home > Press > Industrial Nanotech Announces Completion of Audited Financials
Industrial Nanotech, Inc., (Pink Sheets:INTK), an emerging global leader in nanotechnology, announced today that the audit of the Company's financials since inception in 2004 through fiscal year end 2006 has been completed, enabling investors to have confidence in its financial integrity and organization. This satisfies the compliance requirements of many brokerage firms and institutional investors which have not been permitted to purchase the company's stock for their clients prior to the audit completion.
Industrial Nanotech Announces Completion of Audited Financials
NAPLES, FL | Posted on June 20th, 2007
"We are proud to announce the completion of the audit of our financials since the original formation of the Company with no findings of any irregularities," said Stuart Burchill, CEO of Industrial Nanotech. "It is an important step for Industrial Nanotech as it moves to the next level. We will continue to provide audited financials from this point forward."
The audit was completed by an independent third party, Moore & Associates, Chartered Accountants and Advisors, verifying commitment to integrity and ethical standards in financial and organizational oversight. Following this thorough examination, the auditing firm was able to issue an unqualified opinion regarding each of the areas described above.
About Industrial Nanotech, Inc.
Industrial Nanotech Inc. is rapidly emerging as a global nanoscience solutions and research leader. The Company develops and commercializes new and innovative applications for nanotechnology. Additional information about the Company and its products can be found at their websites, ( http://www.industrial-nanotech.com ) and ( http://www.nansulate.com ).
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
For more information, please click here
For Industrial Nanotech, Inc., Naples
Martin E. Janis & Company, Inc.
Beverly Jedynak, President, 312-943-1100 ext. 12
Martin E. Janis & Company, Inc.
Laura Grock, Vice President, 312-943-1100 ext. 13
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Thinnest feasible membrane produced April 17th, 2014
INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014
Engineers develop new materials for hydrogen storage April 15th, 2014
Industrial Nanotech, Inc. Lands First Major Order from Pemex, Mexico’s State-Owned Oil and Gas Company April 14th, 2014
MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014
Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their March 17th, 2014
Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014
Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014